Royal Bank Of Canada Reaffirms “Buy” Rating for Select Medical Holdings Corporation (SEM)

Select Medical Holdings Corporation (NYSE:SEM)‘s stock had its “buy” rating reissued by investment analysts at Royal Bank Of Canada in a research report issued to clients and investors on Friday. They presently have a $19.00 price target on the health services provider’s stock. Royal Bank Of Canada’s price objective would suggest a potential upside of 6.15% from the company’s current price.

A number of other equities research analysts also recently issued reports on the stock. Zacks Investment Research downgraded shares of Select Medical Holdings Corporation from a “buy” rating to a “hold” rating in a research report on Tuesday. ValuEngine downgraded shares of Select Medical Holdings Corporation from a “buy” rating to a “hold” rating in a research report on Monday, October 2nd. JMP Securities lifted their price target on shares of Select Medical Holdings Corporation from $10.00 to $12.00 and gave the company a “market underperform” rating in a research report on Monday, August 7th. Deutsche Bank AG lifted their price target on shares of Select Medical Holdings Corporation from $20.00 to $22.00 and gave the company a “hold” rating in a research report on Monday, August 7th. Finally, Benchmark Co. lifted their price target on shares of Select Medical Holdings Corporation from $17.00 to $20.00 and gave the company a “buy” rating in a research report on Monday, August 7th. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating and three have assigned a buy rating to the stock. Select Medical Holdings Corporation has an average rating of “Hold” and a consensus target price of $17.57.

Select Medical Holdings Corporation (NYSE:SEM) last posted its quarterly earnings results on Thursday, August 3rd. The health services provider reported $0.32 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.25 by $0.07. Select Medical Holdings Corporation had a net margin of 1.95% and a return on equity of 9.61%. The company had revenue of $1.12 billion during the quarter, compared to the consensus estimate of $1.13 billion. During the same period last year, the firm earned $0.23 EPS. The company’s revenue for the quarter was up 2.1% on a year-over-year basis.

ILLEGAL ACTIVITY WARNING: This story was first reported by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this story on another domain, it was illegally stolen and republished in violation of United States & international trademark & copyright laws. The original version of this story can be accessed at https://sportsperspectives.com/2017/10/13/royal-bank-of-canada-reaffirms-buy-rating-for-select-medical-holdings-corporation-sem.html.

In related news, insider David S. Chernow sold 133,025 shares of Select Medical Holdings Corporation stock in a transaction on Thursday, September 14th. The shares were sold at an average price of $17.85, for a total transaction of $2,374,496.25. Following the transaction, the insider now owns 729,815 shares in the company, valued at approximately $13,027,197.75. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 19.93% of the company’s stock.

Several large investors have recently bought and sold shares of SEM. PNC Financial Services Group Inc. lifted its holdings in shares of Select Medical Holdings Corporation by 0.8% during the 1st quarter. PNC Financial Services Group Inc. now owns 8,313 shares of the health services provider’s stock valued at $111,000 after acquiring an additional 70 shares in the last quarter. Pacad Investment Ltd. lifted its holdings in shares of Select Medical Holdings Corporation by 58.7% during the 2nd quarter. Pacad Investment Ltd. now owns 7,300 shares of the health services provider’s stock valued at $112,000 after acquiring an additional 2,700 shares in the last quarter. Ameritas Investment Partners Inc. acquired a new position in shares of Select Medical Holdings Corporation during the 1st quarter valued at $123,000. Envestnet Asset Management Inc. lifted its holdings in shares of Select Medical Holdings Corporation by 1.2% during the 1st quarter. Envestnet Asset Management Inc. now owns 9,317 shares of the health services provider’s stock valued at $125,000 after acquiring an additional 107 shares in the last quarter. Finally, Riverhead Capital Management LLC lifted its holdings in shares of Select Medical Holdings Corporation by 78.0% during the 2nd quarter. Riverhead Capital Management LLC now owns 8,722 shares of the health services provider’s stock valued at $134,000 after acquiring an additional 3,822 shares in the last quarter. Institutional investors and hedge funds own 79.02% of the company’s stock.

Select Medical Holdings Corporation Company Profile

Select Medical Holdings Corporation is an operator of specialty hospitals, outpatient rehabilitation clinics and occupational medicine centers in the United States. The Company’s segments include specialty hospitals, outpatient rehabilitation, Concentra and Other. The specialty hospitals segment consists of hospitals designed to serve the needs of long term acute patients and hospitals designed to serve patients that require intensive medical rehabilitation care.

Analyst Recommendations for Select Medical Holdings Corporation (NYSE:SEM)

Receive News & Ratings for Select Medical Holdings Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical Holdings Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply